Prelude Therapeutics Inc — Form D

Prelude Therapeutics Inc of Wilmington, DE, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-17. The offering totals $60.0M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
David MauroExecutive OfficerCambridge, MA
Peggy ScherleExecutive OfficerWilmington, DE
David BonitaDirectorNew York, NY
Mardi C DierDirectorSouth San Francisco, CA
Paul FriedmanDirectorRochester, MN
Victor SandorDirectorWilmington, DE
Peggy C ScherleExecutive OfficerWilmington, DE
Christopher C PierceExecutive OfficerWilmington, DE
Deborah C MorosiniExecutive OfficerWilmington, DE
Krishna VaddiDirectorWilmington, DE
Krishna VaddiExecutive OfficerWilmington, DE
Brian C PiperExecutive OfficerWilmington, DE
Kelvin NeuDirectorWilmington, DE
David C MauroExecutive OfficerWilmington, DE
Andrew C CombsExecutive OfficerWilmington, DE
Juan LuengoExecutive OfficerWilmington, DE

Other filings by this issuer (4)

FiledFormOfferingSold
2020-08-28D$50.0M$50.0M
2018-08-17D/A$30.0M$30.0M
2017-10-20D$12.0M$12.0M
2016-07-11D$5.0M$5.0M

More